ELLIPSE Study: A Phase 1 study evaluating the tolerance of bevacizumab nasal spray in the treatment of epistaxis in hereditary hemorrhagic telangiectasia

Background: Hereditary hemorrhagic telangiectasia (HHT) is a dominantly inherited genetic vascular disorder in which epistaxis is the most frequent manifestation, responsible for high morbidity. Management of this symptom has no standard, and local treatments are often aggressive. Their efficacy is...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Dupuis-Girod, Sophie, Ambrun, Alexis, Decullier, Evelyne, Samson, Géraldine, Roux, Adeline, Fargeton, Anne-Emmanuelle, Rioufol, Catherine, Schwiertz, Verane, Disant, François, Chapuis, François, Donazzolo, Yves, Paintaud, Gilles, Edery, Patrick, Faure, Frederic
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Landes Bioscience 2014
Gaiak:
Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4011923/
https://ncbi.nlm.nih.gov/pubmed/24481211
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/mabs.28025
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak